Synergistic benefit of thiazolidinedione and sodium-glucose cotransporter 2 inhibitor for metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: a 24-week, open-label, randomized controlled trial

Authors

Byung‐Wan Lee (ORCID: https://orcid.org/0000-0002-9899-4992)
Min Heui Yu (ORCID: https://orcid.org/0000-0003-3787-795X)
Bong Soo (ORCID: https://orcid.org/0000-0003-0542-2854)
Hyungjin Rhee (ORCID: https://orcid.org/0000-0001-7759-4458)
Eun Seok Kang (ORCID: https://orcid.org/0000-0002-0364-4675)
Yongin Cho (ORCID: https://orcid.org/0000-0002-4645-816X)
Jae Hyun Bae (ORCID: https://orcid.org/0000-0002-1384-6123)
Yong‐ho Lee (ORCID: https://orcid.org/0000-0002-6219-4942)
Minyoung Lee (ORCID: https://orcid.org/0000-0002-9333-7512)
Seonki Hong (ORCID: https://orcid.org/0000-0003-1440-5167)

Institutions

Inha University (KR)
Yonsei University (KR)
Severance Hospital (KR)
Hallym University Kangnam Sacred Heart Hospital (KR)
Yonsei University Health System (KR)

Publication Details

Journal: BMC Medicine
Published: 2025-05-07
DOI: https://doi.org/10.1186/s12916-025-04017-x
Citations: 8
Primary Topic: Liver Disease Diagnosis and Treatment
Type: article
Field-Weighted Citation Impact: 10.83

Funders

Yuhan
Yonsei University
Yonsei University College of Medicine

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Synergistic benefit of thiazolidinedione and sodium-glucose cotransporter 2 inhibitor for metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: a 24-week, open-label, randomized controlled trial

Byung‐Wan Lee, Min Heui Yu, Bong Soo, Hyungjin Rhee et al.

May 7, 2025

8 citations

BMC Medicine

Liver Disease Diagnosis and Treatment

10.83

article

Synergistic benefit of thiazolidinedione and sodium-glucose cotransporter 2 inhibitor for metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: a 24-week, open-label, randomized controlled trial

Byung‐Wan Lee, Min Heui Yu, Bong Soo, Hyungjin Rhee, Eun Seok Kang, Yongin Cho, Jae Hyun Bae, Yong‐ho Lee, Minyoung Lee, Seonki Hong

May 7, 2025article en

8 citations

Abstract

No abstract available for this paper.

BMC MedicineVol. 23(1)

Inha University (KR), Yonsei University (KR), Severance Hospital (KR), Hallym University Kangnam Sacred Heart Hospital (KR), Yonsei University Health System (KR)

Yuhan, Yonsei University, Yonsei University College of Medicine

Good health and well-being

Openalex Percentile: Top 1%

Liver Disease Diagnosis and Treatment

10.83

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Synergistic benefit of thiazolidinedione and sodium-glucose cotransporter 2 inhibitor for metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: a 24-week, open-label, randomized controlled trial — Byung‐Wan Lee, Min Heui Yu, et al. · BMC Medicine (2025) | TGRS Research Map | TGRS